首页> 外文期刊>Brain research >Cerebral ischemia combined with beta-amyloid impairs spatial memory in the eight-arm radial maze task in rats.
【24h】

Cerebral ischemia combined with beta-amyloid impairs spatial memory in the eight-arm radial maze task in rats.

机译:在八臂放射状迷宫大鼠中,脑缺血结合β-淀粉样蛋白会损害空间记忆。

获取原文
获取原文并翻译 | 示例
       

摘要

beta-Amyloid (Abeta), a major component of senile plaques in Alzheimer's disease, has been implicated in neuronal cell death, a characteristic feature of this condition. In our previous experiments using primary cultures of hippocampal neurons, Abeta treatment induced neuronal cell death, displaying morphological characteristics of apoptosis that was significantly enhanced by hypoxia. Based on these results, we developed a simple in vivo rat model of Alzheimer's disease using cerebral ischemia, instead of hypoxia, combined with continuous intracerebroventricular administration of Abeta. The combination of cerebral ischemia and Abeta administration, but not either treatment alone, significantly impaired spatial memory in an eight-arm radial maze. A microdialysis study showed that spontaneous release of acetylcholine (ACh) from the dorsal hippocampus had a tendency to decrease in response to Abeta treatment alone or the combination of ischemia and Abeta. High K(+)-evoked increase in ACh release had a tendency to be inhibited by either ischemia or Abeta treatment alone and was significantly inhibited by the combination of both. Moreover, combination of ischemia and Abeta induced apoptosis of pyramidal neurons in the CA1 region of the hippocampus. Donepezil, a drug currently in clinical use for Alzheimer's disease, improved the impairment of spatial memory induced by cerebral ischemia combined with Abeta. These findings suggest that ischemia is an important factor facilitating the symptoms of Alzheimer's disease, and this model may be useful for developing new drugs for the treatment of Alzheimer's disease.
机译:β-淀粉样蛋白(Abeta)是阿尔茨海默氏病中老年斑的主要成分,与神经元细胞死亡有关,这是该病的特征。在我们先前使用海马神经元原代培养物进行的实验中,Abeta处理诱导神经元细胞死亡,显示出细胞凋亡的形态学特征,缺氧显着增强了凋亡。基于这些结果,我们开发了一种简单的体内大鼠模型,该模型使用脑缺血而非缺氧结合连续的脑室内Abeta给药来治疗阿尔茨海默氏病。脑缺血和Abeta的组合使用,但不能单独使用两种方法,都会严重损害八臂径向迷宫中的空间记忆。一项微透析研究表明,自背海马区自发释放乙酰胆碱(ACh)时,对单独使用Abeta治疗或缺血与Abeta联合治疗有缓解的趋势。高K(+)引起的ACh释放增加倾向于被单独的缺血或Abeta治疗抑制,并且被两者的组合显着抑制。此外,缺血和Aβ的组合可诱导海马CA1区锥体神经元的凋亡。多奈哌齐是目前在临床上用于治疗阿尔茨海默氏病的药物,可改善由脑缺血与Abeta结合引起的空间记忆障碍。这些发现表明,缺血是促进阿尔茨海默氏病症状的重要因素,该模型对于开发用于治疗阿尔茨海默氏病的新药物可能有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号